Ning Liao

机构：Sun Yat-sen University, Alibaba Group (Cayman Islands), Alibaba Group (United States), Guangdong Academy of Medical Sciences, Alibaba Group (China) · ORCID：0000-0002-1780-5652

发表论文 116 篇 · 总被引 1524 次 · h-index 20

代表论文

• Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial (2024 · Nature Communications · 被引 32)
• A radiogenomic multimodal and whole-transcriptome sequencing for preoperative prediction of axillary lymph node metastasis and drug therapeutic response in breast cancer: a retrospective, machine learning and international multicohort study (2024 · International Journal of Surgery · 被引 29)
• Genistein alleviates rheumatoid arthritis by inhibiting fibroblast-like synovial exosome secretion regulated by the Rab27/nSMase2/Mfge8 pathway (2025 · Food & Function · 被引 13)
• Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer (2024 · Journal of Clinical Oncology · 被引 11)
• Identification of biomarker associated with Trop2 in breast cancer: implication for targeted therapy (2024 · Discover Oncology · 被引 7)
• Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients (2025 · JCO Clinical Cancer Informatics · 被引 6)